Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Mr. Robert W. Azelby M.B.A. |
IPO Date | Aug. 10, 2021 |
Location | United States |
Headquarters | 23515 NE Novelty Hill Road, Redmond, WA, United States, 98053 |
Employees | 9 |
Sector | Healthcare |
Industry | Biotechnology |
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
NA
NA
NA
NA
NA
NA
NA
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email